Each year, 1·3 million people die from viral hepatitis, and mortality is increasing.1 This World Hepatitis Day, all stakeholders must break down the barriers to hepatitis elimination, including ending ...

Hepatitis B virus, a killer of more than one million people each year, is a notoriously wily virus, often lingering and ...

The U.S. Food and Drug Administration has extended its review of GSK's blood cancer drug, Blenrep, as a combination treatment ...

Sydnie Mason laughs with her lab partner at the SNC GlaxoSmithKline Summer Immersion Experience in Biotech, a biotechnology ...

A two-week program at North Carolina Central University gives attendees a $1,000 stipend, field trips to local businesses, ...

Amid plans to transfer manufacturing for an investigational vaccine to a souped-up plant in Pennsylvania, GSK is parting ways ...

The Cambridge site of an international biotechnology company will cease manufacturing, leaving 150 people without a job.

British biopharmaceutical company GlaxoSmithKline will lay off 150 employees in its Cambridge operations by the end of March ...

Most Oncologic Drugs Advisory Committee members took issue with the lack of dosing optimization and the lack of US patient ...

The analyst further reasoned that the high ocular toxicity rates, including keratopathy and visual acuity changes, are ...

This month in the Zantac litigation, the Delaware Supreme Court tossed all the plaintiffs’ experts in thousands of cases, ...

Glaxosmithkline, with multiple operations in Montco, just scored a major regulatory win that could reshape how lupus nephritis is treated in children, ...